Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01588015
What this trial is testing

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more
City of Hope Medical Center 36
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00002832
What this trial is testing

Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00045435
What this trial is testing

Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
Fred Hutchinson Cancer Center 17
Large-scale testing (Phase 3)Active Not RecruitingNCT06216158
What this trial is testing

Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 411
Testing effectiveness (Phase 2)Study completedNCT03690115
What this trial is testing

Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) in FLT3-ITD AML Patients

Who this might be right for
Leukemia, Myeloid, Acute
Versailles Hospital 23
Testing effectiveness (Phase 2)Study completedNCT04690192
What this trial is testing

CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)Looking for participantsNCT05091372
What this trial is testing

Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Myeloma Multiple
M.D. Anderson Cancer Center 94
Not applicableStudy completedNCT05103995
What this trial is testing

Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell Transplantation

Who this might be right for
Hematological MalignanciesHaploidentical Stem Cell Transplantation
First Affiliated Hospital of Zhejiang University 510
Testing effectiveness (Phase 2)Study completedNCT02141451
What this trial is testing

ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL

Who this might be right for
Diffuse Large B Cell Non-Hodgkin Lymphoma
Masonic Cancer Center, University of Minnesota 30
Not applicableLooking for participantsNCT07253129
What this trial is testing

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 88
Large-scale testing (Phase 3)Study completedNCT03748953
What this trial is testing

Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 37
Testing effectiveness (Phase 2)Looking for participantsNCT04959903
What this trial is testing

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

Who this might be right for
Hematological Malignancies
Smart Immune SAS 36
Testing effectiveness (Phase 2)Study completedNCT01502072
What this trial is testing

Respiratory Syncytial Virus - RSV Protocol

Who this might be right for
Bone Marrow Transplant InfectionInfection in Marrow Transplant RecipientsRespiratory Syncytial Virus Infections+3 more
M.D. Anderson Cancer Center 48
Early research (Phase 1)Ended earlyNCT01045928
What this trial is testing

Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Adult Non-Hodgkin LymphomaAdult Grade III Lymphomatoid GranulomatosisContiguous Stage II Adult Burkitt Lymphoma+77 more
Case Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Ended earlyNCT04530487
What this trial is testing

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

Who this might be right for
Desmoplastic Small Round Cell TumorEwing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Desmoplastic Small Round Cell Tumor+9 more
M.D. Anderson Cancer Center 1
Not applicableUnknownNCT06484049
What this trial is testing

Prospective Observational Clinical Study on Changes in Cognitive Levels in Elderly Patients Before and After Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)UnknownNCT00004128
What this trial is testing

Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 2,000
Testing effectiveness (Phase 2)WithdrawnNCT07349771
What this trial is testing

Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT01827137
What this trial is testing

WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Sellas Life Sciences Group 20
Next Page